NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 59220 | [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt | 0.0123744972338278 | -0.18199563 |
NSC 609699 | Topotecan hydrochloride | 0.0123744972338278 | -0.0047834829 |
NSC 624233 | Null | 0.0123744972338278 | -0.15788502 |
NSC 639734 | Null | 0.0123744972338278 | 0.12930362 |
NSC 653860 | Null | 0.0123744972338278 | 0.24371832 |
NSC 657305 | Null | 0.0123744972338278 | 0.027638645 |
NSC 676774 | Olean-12-en-28-oic acid, 3-.beta.-[2-O-(.beta.-D-glucopyranosyl)- .beta.-D-glucopyranosyloxy]-, [2-O-[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-6-deoxy-.beta.-D-gulopyranosyl]- .b | 0.0123744972338278 | -0.057020943 |
NSC 677261 | Null | 0.0123744972338278 | -0.10055855 |
NSC 681635 | Camptothecin Derivative | 0.0123744972338278 | 0.065977831 |
NSC 683661 | Acetic acid, amino-, 9-[[(amino)carbonyl]oxy]-13-(2-amino- 1-oxoethoxy)-8,14-dimethoxy-4,10,12,16-tetramethyl- 3,20,22-trioxo-19-[(2-propenyl)amino]-2-azabicyclo [16.3.1]docosa-1(21),4,6,10,18-pentae | 0.0123744972338278 | -0.34339937 |